Abstract: Small cell carcinoma of cervix (SCCC) is a rare and high malignant neuroendocrine tumor. Because of its strong invasion, metastasis in early stage and easy recurrence, the prognosis is poor. Its diagnosis is based on pathomorphology, and immune-histochemistry biomarkers can improve its diagnosis. Combined therapy is recommended. Postoperative platinum/etoposide(PE), vincristine/adriamycin/cyclophosphamide(VAC) or taxel /carboplatin(TP) chemotherapy can improve the prognosis.

Key words: Uterine cervical neoplasms, Surgical procedures, operative, Drug therapy, Radiotherapy